NewtekOne (NEWT) extends 12‑month buyback, up to 1,000,000 shares

NewtekOne, Inc. extended its share repurchase program for twelve months.

Rhea-AI Filing Summary

NewtekOne, Inc. extended its share repurchase program for twelve months. The authorization permits the company to buy back up to 1,000,000 shares of common stock.

The timing and size of any repurchases will be determined at the company’s discretion based on market conditions, applicable legal requirements, the company’s capital needs, and alternative uses of capital. The company has no obligation to repurchase any shares under the program.

Insights

Corporate finance analyst

Extension preserves share repurchase flexibility; execution remains discretionary.

NewtekOne extended its buyback authorization for twelve months, allowing repurchases of up to 1,000,000 common shares. The Board approved the extension on November 7, 2025, maintaining capacity rather than initiating a new transaction.

Repurchases are at management’s discretion and contingent on factors the company lists: market conditions, legal requirements, capital needs, and alternative uses of capital. This means activity could vary widely and may not occur.

Without details on valuation, liquidity, or planned cadence, the near-term impact is neutral. Actual outcomes depend on if and when the company allocates capital to repurchases under this authorization.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NEWT announce in this 8-K?

The Board approved a twelve month extension of NewtekOne’s share repurchase program.

How many shares can NewtekOne (NEWT) repurchase under the program?

The authorization permits repurchases of up to 1,000,000 shares of common stock.

Is NewtekOne required to repurchase shares under this program?

No. The company has no obligation to repurchase any amount of its common stock.

What factors will influence the timing and amount of NEWT repurchases?

Management cites market conditions, applicable legal requirements, the company’s capital needs, and alternative uses of capital.

When was the extension of the repurchase program approved?

The Board approved the extension on November 7, 2025.

How long does the extended repurchase authorization for NEWT last?

It lasts for twelve months from the approval date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/07/2025 - 02:56 PM EST Learn about SEC filing dates

FALSE000158798700015879872025-11-072025-11-070001587987newt:CommonStockParValue002PerShareMember2025-11-072025-11-070001587987newt:FivePointFiveZeroPercentNotesDue2026Member2025-11-072025-11-070001587987newt:EightPointZeroPercentNotesDue2028Member2025-11-072025-11-070001587987newt:EightPointFivePercentNotesDue2029Member2025-11-072025-11-070001587987newt:EightPointSixTwoFivePercentNotesDue2029Member2025-11-072025-11-070001587987newt:DepositarySharesMember2025-11-072025-11-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

November 7, 2025

Date of Report (date of Earliest Event Reported)

NEWTEKONE, INC.

(Exact Name of Company as Specified in its Charter)

Maryland			814-01035			46-3755188
(State or Other Jurisdiction of Incorporation or Organization)			(Commission File No.)			(I.R.S. Employer Identification No.)

4800 T Rex Avenue, Suite 120, Boca Raton, Florida 33431

(Address of principal executive offices and zip code)

(212) 356-9500

(Company’s telephone number, including area code)

(Former name or former address, if changed from last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.02 per share

NEWT

Nasdaq Global Market LLC

5.50% Notes due 2026

NEWTZ

Nasdaq Global Market LLC

8.00% Notes due 2028

NEWTI

Nasdaq Global Market LLC

8.50% Notes due 2029

NEWTG

Nasdaq Global Market LLC

8.625% Notes due 2029

NEWTH

Nasdaq Global Market LLC

Depositary Shares, each representing a 1/40th interest in a share of 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B

NEWTP

Nasdaq Global Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Forward-Looking Statements

Statements in NewtekOne, Inc.’s (“NewtekOne” or the “Company”) Current Report on Form 8-K contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and beliefs and are subject to significant risks and uncertainties. Actual results may differ materially from those set forth in the forward-looking statements. See “Note Regarding Forward-Looking Statements” and the sections entitled “Risk Factors” in the Company's filings with the Securities and Exchange Commission which are available on NewtekOne's website (https://investor.newtekbusinessservices.com/sec-filings) and on the Securities and Exchange Commission’s website (www.sec.gov). Any forward-looking statements made by or on behalf of NewtekOne speak only as to the date they are made, and NewtekOne does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.

Item 8.01.     Other Events.

On November 7, 2025, the Board of Directors (the "Board") of NewtekOne approved a twelve month extension of the repurchase program (the “Program”) the Board previously approved on November 1, 2024, under which the Company may repurchase up to 1,000,000 shares of the Company's common stock. The actual timing and amount of any repurchases under the Program will be determined by the Company in its discretion, and will depend on a number of factors, including market conditions, applicable legal requirements, the Company's capital needs and whether there is a better alternative use of capital. The Company has no obligation to repurchase any amount of its common stock under the Program.

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			NEWTEKONE, INC.
Date: November 7, 2025			By:			/S/    BARRY SLOANE
						Barry Sloane
						Chief Executive Officer, President and Chairman of the Board